ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 83 filers reported holding ACELRX PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,323,000 | -14.4% | 6,329,202 | 0.0% | 0.03% | -24.4% |
| Q2 2022 | $1,546,000 | -14.4% | 6,329,202 | 0.0% | 0.04% | 0.0% |
| Q1 2022 | $1,807,000 | -49.0% | 6,329,202 | +0.1% | 0.04% | -45.1% |
| Q4 2021 | $3,544,000 | -9.0% | 6,325,902 | +65.6% | 0.08% | 0.0% |
| Q3 2021 | $3,896,000 | -25.5% | 3,819,402 | +0.8% | 0.08% | -20.4% |
| Q2 2021 | $5,228,000 | -18.8% | 3,788,757 | +0.1% | 0.10% | -26.4% |
| Q1 2021 | $6,435,000 | +37.2% | 3,785,457 | +0.1% | 0.14% | +41.4% |
| Q4 2020 | $4,690,000 | -12.5% | 3,782,457 | +0.2% | 0.10% | -27.2% |
| Q3 2020 | $5,358,000 | – | 3,773,585 | – | 0.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 6,574,060 | $27,874,000 | 1.68% |
| SENZAR ASSET MANAGEMENT, LLC | 798,381 | $3,385,000 | 0.58% |
| Cormorant Asset Management, LP | 850,000 | $3,604,000 | 0.48% |
| Palo Alto Investors LP | 2,135,739 | $9,056,000 | 0.40% |
| Opus Point Partners Management, LLC | 99,959 | $424,000 | 0.34% |
| Granahan Investment Management | 1,582,237 | $6,709,000 | 0.19% |
| Joel Isaacson & Co., LLC | 70,660 | $300,000 | 0.08% |
| MARINER INVESTMENT GROUP LLC | 59,700 | $253,000 | 0.06% |
| MYCIO WEALTH PARTNERS, LLC | 75,000 | $318,000 | 0.06% |
| Cornerstone Capital, Inc. | 59,200 | $251,000 | 0.06% |